Announcements Trials

Browse Landscape

Phase

Status

Completed 147 Terminated 39 Unknown 28 Active not recruiting 10 Recruiting 9 Withdrawn 6 Suspended 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Cancer, Papillary 1

Interventions

Cisplatin 122 Carboplatin 120 Drug Therapy 104 Bevacizumab 101 Capecitabine 96 Oxaliplatin 95 Radiotherapy 92 Gemcitabine 88 Paclitaxel 87 tislelizumab 84 Cyclophosphamide 83 Specimen Handling 80 pembrolizumab 76 toripalimab 66 Magnetic Resonance Spectroscopy 63 Fluorouracil 61 sintilimab 58 Injections 57 anlotinib 51 Docetaxel 51 Surgical Procedures, Operative 48 130-nm albumin-bound paclitaxel 48 fludarabine 45 Pemetrexed 43 Standard of Care 42 Biopsy 42 venetoclax 41 Irinotecan 41 lenvatinib 40 Leucovorin 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × Mitoxantrone × Clear all

NCT07354698 2026-01-21

MHI

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 4 Not yet recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡